The Center for Tobacco Products (CTP)[1] was established by the United States Food and Drug Administration as a result of the Family Smoking Prevention and Tobacco Control Act[2] signed by President Obama in June 2009. The FDA center was responsible for the implementation of the Family Smoking Prevention and Tobacco Control Act.
The smoking prevention and tobacco law established regulatory controls for tobacco products:[3]
- Setting performance standards for tobacco products
- Reviewing premarket applications for new and modified risk of tobacco product
- Requirement of warning labels for tobacco products
- Enforcing advertising and promotion restrictions for tobacco products
The U.S. mandated legislation was a historic milestone for the U.S. FDA. The enacted law used to assist with the federal agency regulatory efforts and initiatives to curb the suspected health hazards for tobacco products on an annual basis.
See also
edit- Little Lungs in a Great Big World, public service announcement series that is part of a campaign for the CTP
References
edit- ^ "About U.S. FDA Center for Tobacco Products". Food and Drug Administration. Archived from the original on 2019-04-22. Retrieved 2019-12-16.
- ^ "Family Smoking Prevention and Tobacco Control Act (Public Law 111-31)" (PDF). Archived (PDF) from the original on 2011-10-16. Retrieved 2011-09-20.
- ^ "U.S. FDA Tobacco Products Information". Food and Drug Administration. Archived from the original on 2017-11-01. Retrieved 2019-12-16.
External links
edit
- Official website
- Tobacco Products at FDA.gov
.svg){kind=small} | This United States government–related article is a stub. You can help Wikipedia by expanding it. |